Ligand validation:6HF6

7MT: Tb-Xo4

7MT is a Ligand Of Interest in 6HF6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HF6_7MT_A_201	68%	14%	0.153	0.964	1.41	2.38	2	5	1	0	100%	0.8
6HF6_7MT_B_201	50%	14%	0.206	0.959	1.49	2.32	2	8	1	0	100%	0.8
6HF6_7MT_C_201	42%	16%	0.238	0.958	1.49	2.19	2	9	1	0	100%	0.8
6F2F_7MT_A_201	93%	23%	0.092	0.989	1.25	1.89	3	7	0	0	100%	0.8
6F2H_7MT_F_203	87%	16%	0.108	0.979	1.47	2.18	3	5	1	0	100%	0.8
6F2J_7MT_A_205	98%	33%	0.074	0.995	1.11	1.51	2	4	0	0	100%	0.85
6F2M_7MT_D_302	95%	21%	0.092	0.995	1.46	1.84	3	7	0	0	100%	0.8
6FRN_7MT_D_508	91%	36%	0.104	0.99	1.11	1.42	1	2	0	0	100%	1
6F2I_7MT_A_202	90%	34%	0.105	0.99	1.17	1.41	2	2	0	0	100%	0.85
8BPQ_7MT_B_402	90%	21%	0.107	0.992	1.38	1.95	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.